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Abstract Small GTP binding proteins of the rablYPT family 
art, essential regulators of vectorial transport in the eukaryotic 
cell. Members of the rab/YPT1 family are found on the cytoplas- 
mic surface of distinct intracellular membrane compartments. 
Membrane attachment is facilitated by a C-terminal geranylger- 
anyl moiety. In this report we investigated posttranslational mod- 
ification and membrane binding of the rab6 protein, a member of 
the rab/YPT family located on the Golgi apparatus. A set of point 
mutations, which simulate the GDP or GTP bound conformation, 
was introduced into the rab6 cDNA. The mutated cDNAs were 
expressed in insect cells and the ability of the protein products 
to undergo geranylgeranyl modification and membrane associa- 
tion was assessed by Triton X-114 partition and cell fractionation. 
We report here that the modification of rab6 in insect cells de- 
pends on protein conformation. Only the GDP bound form, but 
not the GTP bound form is isoprenylated and subsequently mem- 
brane bound. 
K~v words: GTP; Ras protein; Intracellular transport; 
R~b proteins; GTPase 
1. Introduction 
['he eukaryotic ellular protein transport between the differ- 
ent membrane compartments of the exo-/endocytotic pathway 
is mediated by vesicles (for review see [1]). These vesicles are 
for med from a donor compartment through the interaction of 
the. lipid bilayer with the coat proteins and the small GTP- 
bil~ding protein ARF. After budding, vesicles are targeted to 
th~ acceptor membrane. Targeting and fusion is mediated by 
se eral different factors, namely the SNAPs, NSF and the 
SIX ARE proteins, which are all complexed in the 20S particle 
[2. ~]. The principal components of budding and fusion events 
ar~ conserved in most transport processes throughout the exo/ 
en~locytotic machinery. The major regulatory event in these 
transport processes i GTP hydrolysis (for review see [4]). So 
far three classes of GTP-binding proteins involved in vesicular 
transport have been described. In addition to the ARF proteins 
and the heterotrimeric G-proteins, an increasing number of rab 
GrPases are known to regulate intracellular vesicle transport 
[5.6]. Today rab proteins represent a subfamily of the ras super- 
*( )rresponding author. Fax: (49) (251) 83-8390. 
Ab 5reviations. NSF, N-ethylmaleimide-sensitive factor; SNAP, soluble 
NSF attachment protein; SNARE, SNAP receptor; GAP, GTPase ac- 
tivating protein; GDI, guanosine nucleotide dissociation inhibitor; 
GI)S, guanosine nucleotide dissociation stimulating protein; GTPTS, 
gu;,nosine 5'-O-thiophosphate; REP rab escort protein. 
family with more than 30 members which are localized on the 
cytoplasmic surface of distinct organelle membranes. 
The functional status of the rab proteins is determined by the 
nucleotide bound to the protein. Rab proteins cycle between an 
active form in which GTP is bound and an inactive form in 
which GDP is bound. The hydrolysis of the nucleotide results 
in a conformational teration of the protein. The activity of 
these proteins requires an array of accessory factors which 
regulate the GTPase cycle. At present four classes of proteins 
are known to control tab GTPases [7]. 
(1) The GTPase activating protein, GAR which enhances the 
low endogenous GTPase activity. 
(2) The guanosine nucleotide xchange factor, GEE which 
accelerates the exchange of GDP to GTR 
(3) The rab escort protein, RER which is a part of the tab 
geranylgeranyl transferase complex. 
(4) The guanosine nucleotide dissociation inhibitor, GDI, a 
molecular chaperone of cytosolic rab proteins. 
GDI is known to interact with most of the rab family mem- 
bers [8]. Four functions have so far been assigned to GDI: 
( 1 ) it inhibits the exchange of bound GDP to GTP; (2) it accom- 
panies cytosolic rab proteins; (3) it directs the rab proteins to 
their target membranes [9], where, with subsequent exchange 
of GDP for GTR they become membrane bound [9]; and (4) 
it can extract rab proteins from the membranes [10,11]. 
Similar to other ras-like proteins, rab proteins also undergo 
posttranslational modifications, which are essential for their 
function [12]. The rab geranylgeranyl transferase modifies the 
rabs by covalently adding geranylgeranyl groups onto cysteine 
residues [13]. The modified cysteines are found in a CC, CXC, 
CXX or CXXX motif at the C-terminal part of the proteins. 
Nonmodified rab proteins are unable to associate with intracel- 
lular membranes and do not complex with GDI [14]. Complex 
formation constitutes the key event for the tab's entrance into 
their life cycle [8]. In contrast to isoprenylation, carboxy-meth- 
ylation, a second posttranslational modification found on rab 
proteins is neither necessary for the GDI interaction or for 
membrane attachment. 
The rab geranylgeranyl transferase (GG transferase), origi- 
nally termed geranylgeranyl transferase II, is a two component 
enzyme [15]. Nonmodified rab proteins are presented by the 
component A, also called rab escort protein (REP), to the 
catalytic omponent B [16]. Component A can be recycled by 
passing the modified rab proteins onto GDI [16]. Several recent 
studies have investigated the structural requirements for ger- 
anylgeranyl addition to rab proteins. In addition to the cys- 
teines at the C-terminus, internal parts of the rab proteins are 
required for geranylgeranyl modification. For tab6 it was 
shown that the structures of both the effector domain and the 
hypervariable domain determine a modification by the tab GG 
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transferase [17]. The same structures are also involved in target- 
ing the rab6 protein to the Golgi apparatus [17]. Studies on the 
related rab5 protein revealed that addition of geranylgeranyl 
residues depends on the nucleotide bound and thus on the 
protein conformation [18]. The aim of our study was to eluci- 
date how nucleotides liganded to rab6 determine modification 
and subsequent target membrane association. We used the rab6 
protein as a model to study the influence of the protein's con- 
formation on the process of isoprenylation. Different point 
mutations were introduced into the rab6 cDNA resulting in 
proteins which showed conformations corresponding to GTP 
or GDP bound forms ofrab6. To study modification and mem- 
brane binding, mutant cDNAs were introduced into recombi- 
nant baculoviruses and the proteins were expressed in insect Sf9 
cells. The resulting polypeptides were analyzed for their ability 
to undergo posttranslational modification and subsequent 
membrane binding. 
2. Material and methods 
2.1. Chemicals 
Low melting point agarose was purchased from FMC BioProducts 
(Rockland) and nitrocellulose was from Schleicher and Schiill (Dassel, 
Germany). Secondary goat anti-mouse IgG coupled to peroxidase and 
[~-32P]GTP (3000 Ci/mmol) were from Amersham (Braunschweig, Ger- 
many) and [3H]mevalonolactone (20-30 Ci/mmol) from DupontNEN 
(Bad Homburg, Germany). Reticulocyte lysate was obtained from 
Serva (Heidelberg, Germany). 
2.2. Cells and antibodies 
Spodopterafrugiperda (Sf9) cells were grown in Grace insect medium 
supplemented with yeastolate, lactalbumin and 10% heat inactivated 
fetal calf serum (Life Technologies, Eggenstein, Germany). Cells were 
grown at 27°C and subcultured twice a week. Autographa californica 
nuclear polyhedrosis virus (AcMNPV) was purchased from Invitrogen 
(San Diego). The rab6 specific monoclonal ntibody was raised against 
the peptide: NH2-Cys-Tyr-Gly-Met-Glu-Ser-Thr-Gln-Asp-Arg-Ser- 
Arg-Glu-Asp-Met -Ile-Asp- Ile-Lys-Leu- Glu- Lys-Pro-Gln-Glu-Gln- 
Pro-Val-Ser-Glu-Gly-Gly-COOH corresponding toamino acids Gly  t76 
to Gly 2°6 of the human rab6 protein [11]. The myc-specific monoclonal 
antibody 9El0 was described earlier and the hybridoma cells were 
obtained from ATCC [19]. 
2.3. DNA constructs 
The source for the rab6 cDNA was a human cDNA clone [20]. A 
NdeI restriction site was introduced at the start ATG to facilitate the 
insertion of an oligonucleotide coding for the myc-epitope tag. The 
sequence NH2-Met-Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu-His- 
COOH corresponds to an epitope for the monoclonal antibody 9El0, 
originally raised against he c-mye protein [19], and thus allows immu- 
nodetection of the rab6 protein. The structure of the resulting fusion 
protein is depicted in Fig. lB. Point mutations were introduced by 
subcloning the rab6 cDNAs into pTZ19 and by site-directed mutagene- 
sis using the thioanalogue method as described by Taylor [21]. Wildtype 
and mutated cDNA were inserted into the pBlueBacHis A transfer 
vector (Invitrogen, San Diego) using the BamHI site. 
2.4. Generation of recombinant baculoviruses 
Recombinant baculoviruses were generated as described by Guarino 
and Summers [22]. Briefly, 2 x l0  6 cells were cotransfected with 1/2g 
AcMNPV virus DNA and 2/2g plasmid DNA using Ca-phosphate 
transfection. Six days after transfection supernatant was harvested. 
From the supernatant recombinant viruses were plaque purified using 
5-brom-4-chlor-3-indolyl-fl-o-galactopyranoside (Xgal) as a substrate 
to detect he fl-galactosidase activity of the recombinant proteins. 
2.5. Expression of proteins 
1.8 × 107 St'9 cells were infected with wildtype or recombinant bacu- 
loviruses at a multiplicity of infection (moi) of 1. 72 h after infection 
ceils were harvested. Cells were homogenized with 20 strokes in a tight 
fitting Dounce homogenizer in extraction buffer (20 mM Tris-HCl, 
150 mM KCI containing 1mM PMSF and 1 mM NaF). 
2.6. Cell fractionation 
Cell lysate from rab6 wt, T27N or Q72R infected Sf9 cells was 
supplemented to 1 M KC1. Membrane and cytosolic forms of the 
proteins were separated by a 100,000 × g centrifugation step (SW60 
rotor) for 30 min at 4°C. Corresponding aliquots were analyzed on 15% 
SDS-PAGE. 
2.7. Triton X-I14 separation 
Rab6 protein from cell lysates of infected cells were analyzed for their 
geranylgeranyl modification by Triton X-114 partition as described by 
Bordier [23]. 
2.8. SDS-Page and Western blotting 
Samples were analyzed on 15% SDS-PAGE and blotted onto nitro- 
cellulose. Blots were incubated with 1 : 100 dilutions of supernatant 
from 9El0 or 5B10 cultures and horseradish peroxidase conjugated 
secondary antibody. Antibodies were detected using chemilumines- 
cence (Amersham, Braunschweig) and documented on X-ray film (Fuji 
Photo Film Co., Japan). 
2.9. GTP binding assays [24] 
Purified rab6 wt, T27N and Q72R proteins (2/2g each) were sepa- 
rated by SDS-PAGE and blotted onto nitrocellulose. The membranes 
were preincubated in GTP-binding buffer (50 mM NH2PO4 pH 7.5, 10 
/2M MgC12, 2 mM DTT, 0.2% Tween 20, 4/2M ATP) for 30 min at room 
temperature. GTP binding was done with [~-32p]GTP (3000 Ci/mmol) 
at 1/2Ci/ml in binding buffer for 1 h at room temperature. Membranes 
were washed three times for 5 min in binding buffer and exposed to 
X-ray film for 10 min. 
2.10. GTPase assays [25] 
6/2g of purified rab6 wt or mutant proteins were loaded on ice with 
10/2Ci [~-32p]GTP (3000 Ci/mmol) in 50 mM Tris-HC1 pH 7.5, 0.2 mM 
EDTA, 1 mM DTT, 10/2M GTP. The reaction was started by adding 
10/2M MgCI2 and raising the temperature to 37°C. Aliquots were 
removed at various time points and the reaction was stopped by adding 
0.2% SDS, 5 mM EDTA, 50 mM GDP and 50 mM GTE The samples 
were separated by PEI thin-layer chromatography. The amount of 
converted GDP was quantified by scintillation counting. 
2.11. Labeling of SJ9 cells with [3H]mevalonolactone 
48 h after infection (moi = 5), St9 cells were incubated with 50/2M 
compactin for 1 h. Cells were labeled by addition of 50/2Ci of [3H]me- 
valonolactone (20~30 Ci/mmol) for 16 h. Cells were harvested and lysed 
as described above. 
2.12. Geranylgeranylation f bacterial rab6 proteins by reticulocyte 
lysate [26] 
To determine the Km value increasing amounts of bacterially ex- 
pressed rab6 proteins were incubated with 20/21 of untreated reticulo- 
cyte lysate in a 25/21 incubation mix containing 0.5 mM MgCI2, 1 mM 
DTT, 50/2M ZnC12, 1 mM NP-40, 40/2M mevalonolactone and 20/2Ci 
[3H] mevalonolactone (20-30 Ci/mmol) for 1 h at 37°C. To investigate 
modification of rab6 Q72R 0,3/2g of wt or mutant protein were incu- 
bated in a 50/21 assay with 5/2Ci of [3H]mevalonolactone (20-30 Ci/ 
mmol). Reactions were stopped by addition of 0.5 ml of 4% SDS and 
0.5 ml of 30% trichloracetic acid. After 45 min on ice, samples were 
filtered on glass fiber filters (Whatman GF/B). After washings the 
retained radioactivity was determined by scintillation counting. 
3. Results 
To study the influence of guanosine nucleotide attachment 
to rab6 on the geranylgeranyl modification, two different mu- 
tants were generated (Fig. 1A). Rab6 T27N has an exchange 
of threonine-27 to asparagine. This mutation results in a pro- 
tein that binds GDP with a much higher affinity than GTP, thus 
permanently blocking the GTPase activity. The change of Gln 72 
to Arg in rab6 Q72R abolishes the intrinsic GTPase activity of 
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~ame of the changes in the amino- effect of the mutation 
~utant sequence 
• ab6  T27N Thr 27 --> Asn 27 binds GDP --> inactive 
'ab6 Q72R Gin 72 --> Arg 72 no GTPase activity --> 
permanently active 
B 
Amino acids 
Mutations 
T27N mutation Q72R mutation 
GOPIGTP- Phosphoryl group 
binding m • 
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Factor X site B•m Hi Bgl II Pst I Nco I Hind III 
F~g. 1. Structure of the rab6 cDNAs. (A) The table displays the rab6 
m ,atants and the resulting phenotypes and summarizes the amino acid 
cbanges inthe mutant proteins rab6 T27N and Q72R and the resulting 
n tcleotide binding phenotypes. (B) The structure displays of the point 
mutations within rab6 T27N and Q72R and the functional domains 
it, the rab6 polypeptide. The model was modified after Barbacid [12]. 
((!) Structure of the rab6 cDNAs in the recombinant baculovirus. The 
His-tag (His) and the myc-epitope (myc) are located at the 5'-end of the 
r:~b6 coding region. Transcription is initiated at the polyhydrin promo- 
tt~r (PPH). Translation isstarted at an ATG preceding the His-tag. The 
r~rcognition sequence for the factor X protease was inserted between the 
His-tag and the mye-epitope. 
t~te resulting polypeptide; therefore, the protein remains in a 
permanently active form. The topology of the mutants i sum- 
marized in Fig. 1B. To detect he protein after expression i SO 
o,qls, a myc antigenic epitope tag was added to the NH 2 domain. 
qhe resulting BamHI fragment, encoding the mye-tagged 
human rab6 protein, was introduced into the pBlueBacHisA 
t~ansfer vector and fused to a polyhistidine r gion provided by 
lhe vector. The structure of the rab6 DNAs is depictured in 
tig. 1C. 
Sf9 cells were infected with the recombinant viruses and 
~tssayed for expression of rab6 proteins. Fig. 2 shows the results 
(,f Western blot analyses using the rnyc epitope specific 9El0 
~:ntibody (Fig. 2B) or the rab6 specific mab 5B10 (Fig. 2A). 
Neither the mock-infected nor the AcMNPV wt infected cells 
revealed a signal. Cross-reaction of endogenous myc or rab6 
protein is therefore xcluded. In rab6 wt, rab6 T27N and rab6 
Q72R infected cells, recombinant rab6 proteins with a molecu- 
lar weight of about 30 kDa could clearly be detected by either 
the myc tag specific mab 9E 10 (Fig. 2B) or the rab6 specific mab 
5BI0 (Fig. 2A). For rab6 wt and rab6 T27N proteins, the bands 
can be resolved into a double band using shorter exposure times 
(Fig. 2). The relative amounts of both bands vary between 
different experiments and seem to correlate with the amount of 
recombinant proteins in the infected cells. At higher levels of 
expression the lower band becomes more prominent. In rab6 
Q72R virus infected cells only a single band could be observed. 
The appearance of bands with different molecular weights can 
result either from addition of one or two geranylgeranyl groups 
or from proteolytic leavage of the rab6 protein. Addition of 
geranylgeranyl groups to different rab proteins alter the elec- 
trophoretic mobility. While the geranylgeranylated form of 
rablb displays a slower mobility than the nonmodified form, 
for rab3a the opposite behavier was described [27]. It is unlikely 
that the two bands represent the result of proteolytic activities 
inside the myc-rab6 fusions protein since our two antibodies 
recognize both the NHsterminal part (9El0) and the very 
COOH-terminal part (5B10) of the molecule. 
To confirm the integrity and proposed phenotypes of the 
rab6 wt and mutant proteins, Sf9 cells were infected with the 
corresponding recombinant viruses. Proteins were isolated 
from the 100,000 x g supernatants of the cell lysates by chro- 
matography on Ni-affinity matrix. Fig. 3A shows that the rab6 
wt, T27N and Q72R proteins can be purified as a single band 
of about 30 kDa from the lysates of the infected cells. The 
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A 
36 kd-  
31  kd -  
21 .5  kd  - 
B 
36 kd-  
31  kd -  
21 .5  kd -  
Fig. 2. Detection of rab6 proteins in baculovirus-infected c lls Sf9 cells 
were mock infected (mock) or infected with wildtype AcMNPV (wt) or 
recombinant viruses containing rab6 wt, rab6 T27N or rab6 Q72R 
cDNAs at a moi of 1.72 h after infection cells were homogenized. Cell 
lysates were separated on 15% SDS-gels and blotted onto nitrocellulose. 
Blots were incubated with the rab6 specific mab 5B10 (A) or the myc- 
specific mab 9El0 (B) and peroxidase coupled secondary antibodies. 
Proteins were visualized using chemiluminescence as described insec- 
tion 2. 
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purified proteins were separated by SDS-PAGE, transferred to
nitrocellulose and the ability to bind [32p]GTP was assessed by 
an overlay assay. As seen in Fig. 3B rab6 wt and rab6 Q72R 
bind GTP on the blot. In contrast, no GTP-binding activity 
could be observed for the rab6 T27N protein. To detect he 
endogenous GTPase activity, isolated rab6 wt and rab6 Q72R 
proteins were preloaded with [c~-32p]GTE After incubation for 
different imes at 37°C the conversion of GTP to GDP was 
determined by thin-layer chromatography• As seen in Fig. 3C~ 
rab6 Q72R displayed a drastically reduced GTPase activity. 
The results presented inFig. 3A and B confirmed that the three 
different rab6 proteins are expressed in the Sf9 cells in similar 
amounts and in an native form as demonstrated by the GTP- 
binding and GTPase assays• 
To analyze the modification of the different rab6 proteins we 
used Triton X-114 extraction. It has previously been described 
that isoprenylated ras-like proteins are separated into the deter- 
gent-containing phase after lipid modification [17]. The results 
of the separation experiments are shown in Fig• 4A. Sf9 cells 
were infected with the recombinant viruses indicated above and 
harvested 72 h after infection. Equal aliquots were extracted 
with Triton X-114. The aqueous upernatant (S) and the deter- 
gent pellet (P) fractions were analyzed by SDS page and West- 
ern blot analysis using the 5B10 antibody. Fig. 4A shows that 
almost the entire amount of the expressed rab6 wt protein 
migrates into the detergent phase (Fig. 4A, lanes 1 and 2). The 
low molecular weight bands in Fig. 4A most likely represent 
proteolytic degradation production. Since the Triton X-114 
separation procedure includes everal incubations at elavated 
temperatures, degradation is much more prominent than in the 
other experiments. Thus insect cells are clearly able to modify 
the rab6 wt protein posttranslationally. Modification of rab 
proteins in insect cells has been shown before [28]. Rab6 wt and 
rab6 T27N become modified to a similar extent as shown in Fig. 
4A, lanes 1-4. The Triton X-114 extraction demonstrates that 
most of the rab6 wt and rab6 T27N molecules are isoprenylated 
in infected insect cells [17]. The extent of modification depends 
on the period between infection and cell harvest. At postinfec- 
tion times later than 72 h a lower rate of modification is ob- 
served (data not shown). Rab6 Q72R shows a different behav- 
ior. After detergent extraction the total amount of the rab6 
Q72R protein remains in the supernatant. Thus rab6 Q72R is 
-.-) 
Fig. 3. Character izat ion of recombinant  rab6 proteins. (A) Sf9 cells 
were infected with recombinant rab6 wt, T27N and Q72R baculoviruses 
(moi = 1). 72 h after infection cells were harvested. Cell extracts (2.5 
mg/ml) were cleared by centrifugation at 100,000 ×g for 1 h. Superna- 
tants were loaded on a Ni-NTA affinity column• Rab proteins were 
eluted with 50 mM imidazole pH 7.0. Corresponding fractions of the 
total lysates (L), supernatants (S) and eluted rab6 proteins (E) were 
separated on a 15% SDS gel and stained with Coomassie blue. (B) To 
determine the GTP binding properties 2/2g of rab6 wt, rab6 T27N and 
Q72R were purified from Sf9 cells infected with the recombinant viruses 
and separated on 15% SDS gels and transferred tonitrocellulose. The 
membranes were incubated with [~-32P]GTP (3000 Ci/mmol) and ex- 
posed to X-ray film for 10 min. (C) The GTPase activity of rab6 wt and 
tab6 Q72R protein was assessed by preloading of 6/2g of purified 
protein with 10/2Ci of [~-32p]GTP (3000 Ci/mmol). The loaded proteins 
were incubated at 37°C. Aliquots were taken at the time points indi- 
cated. GTP and GDP were separated by thin-layer chromatography. 
The radioactivity in the converted GDP was determined byscintillation 
counting. 
not posttranslationally modified by an isoprene in Sf9 cells. We 
in addition analyzed cell lysates at different postinfection times, 
but were unable to detect a modification of rab6 Q72R at any 
time. Furthermore, we labeled Sf9 cells infected with the recom- 
binant rab6 baculoviruses with [3H]mevalonolactone, a precur- 
sor of the geranylgeranyl moiety. Cell lysates were separated on 
a 15% SDS gel and subjected to fluorography. Fig. 4B shows 
A rab6WT rab6 T27N rab6 Q72R 
M "L S E" L S E" "L S E- 
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55 kd-  
36 kd-  
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that the rab6 wt and the rab6 T27N proteins were labeled with 
the tritiated geranylgeranyl residue while no labeled rab6 pro- 
tel n could be detected in Sf9 cells infected with the Q72R virus. 
Parallel labeling experiments using [35S]methionine r vealed 
that all three proteins were expressed in equal amounts in the 
inlected cells (data not shown). 
Fo investigate whether the lack of modification of tab6 
Q '2R is limited to the Sf9 insect cells we investigated the ability 
ot a mammalian in vitro system to modify the rab6 proteins. 
A n_ C/) CL (n 
I~ r~ N N 
k. h. 0 0 
.Q .Q .Q ,Q .Q 
36  kd-  
31 kd -  
21 .5  kd -  
B 
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~- 0 
C: ~0 SD ~0 
• 'q ~ "Q 
36  kd  - 
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t ig. 4. Isoprenylation f rab6 proteins in infected Sf9 cells Sf9 cells were 
i] fected with rab6 wt, rab6 T27N or rabQ72R recombinant AcMNPV. 
(~) 72 h after infection, cell lysates were extracted with Triton X-114 
a.. described in section 2 and separated into the detergent-containing 
pellet (P) and the aqueous upernatant (S). Under these conditions 
n odified rab6 proteins eparate into the detergent phase while unmod- 
i~ ed apoproteins remain in the supernatant. Aliquots of the pellet and 
s ~pernatant phases were separated on 15% SDS-gels and transferred 
t,, nitrocellulose. Rab6 proteins were detected using the rab specific 
aatibody 5B10. Blots were developed as described in Fig. 2. (B) 48 h 
a~'ter infection 50 pM compactin was added to the medium. Cells were 
1,1beled for 16 h with 50 pCi/ml of [3H]mevalonolactone (20-30 Ci/ 
retool). Cells were harvested and total cell lysates were separated on 
1 ~% SDS gels• After treatment with DMSO/PPO gels were exposed for 
24 h. 
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Fig. 5. In vitro isoprenylation frab6 proteins. Rab6 wt and rab6 Q72R 
were purified from recombinant E. coli. Increasing amounts of rab6 wt 
or rab6 Q72R protein were added to reticulocyte lysate in the presence 
of [3H]mevalonolactone (2~30 Ci/mmol) and incubated for 1 h. The 
amount of modified rab6 protein was determined by TCA precipita- 
tion. The insoluble material was filtered onto glass fiber filters and the 
incorporated radioactivity messuased by scintillation counting. (A) De- 
termination ofthe K,, for rab6 wt. Increasing amounts of rab6 protein 
were incubated inthe in vitro prenylation assay. (B) Comparison of the 
isoprenylation of rab6 wt and rab6 Q72R. Equal amounts of both 
proteins (0.3/lg) were added to the reticulocyte lysate and the amount 
of modified rab6 protein was determined. 
Rab6 wt and rab6 Q72R proteins were expressed and purified 
from E. coli and incubated with reticulocyte lysate in the pres- 
ence of [3H]mevalonolactone as described by Hori et al. [26]. 
Fig. 5A shows that rab6 wt is an efficient substrate for the rab 
geranylgeranyl transferase from the reticulocyte lysate. Increas- 
ing amounts of rab6 protein were added to determine the K m 
value for the rab6 wt protein and a K m value of 1.3/~M could 
be calculated. This is similar to the Km of 1.42 ¢tM which was 
determined by Beranger et al. for the reaction of rab6 and 
purified rab geranylgeranyl transferase [l 7]. While rab6 wt pro- 
tein is modified in the mammalian system, only a negligable 
incorporation of radioactive geranylgeranyl could be detected 
for the rab6 Q72R protein as shown in Fig. 5B. 
To assess the membrane-binding ability of different rab6 
polypeptides, we separated proteins from infected cells into 
cytosolic and membrane fractions. To discriminate between 
loosely associated and tightly bound rab proteins, membranes 
were extracted with 1 M KC1, since rab6 protein is bound to 
the membranes in a salt-resistant manner. Individual fractions 
were assayed for presences of rab proteins by Western blotting. 
The results are summarized in Fig. 6. A substantial mount of 
tab6 wt protein became associated with membranes as demon- 
strated in Fig. 4A, lanes 1 and 2. At later time points after 
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Fig. 6. Membrane association of rab6 proteins in infected Sf9 cells. SO 
cells were infected and harvested as described inFig. 2. Cell lysates were 
adjusted to 1 M KC1 and separated into a cytosolic fraction (S) and a 
membrane fraction (P) by centrifugation at100,000 x g for 1 h at 4°C. 
Corresponding aliquots of the fractions were separated on a 15% SDS- 
gel and blotted onto nitrocellulose. Rab6 was detected by the epitope 
tag specific mab 9El0. Blots were developed as described in Fig. 2. 
infection, the majority of the rab proteins is detected within the 
cytosolic phase (data not shown). The binding of the human 
recombinant rab6 protein to Sf9-derived insect membranes sug- 
gests that the putative membrane receptor of insect cells may 
associate with the primate rab6 protein, since the rab proteins 
become attached to the membrane in a salt-resistant manner. 
The same principle must apply for the GDI and GDS proteins, 
which guide the different rab family members to their target 
membranes [9,10]. Membrane binding characteristics of rab6 
T27N protein mimics those of wt rab6 (Fig. 6, lanes 3 and 4). 
The rab6 Q72R protein remains entirely within the cytosolic 
fraction. This was due to the fact that Q72R protein did not 
become isoprenylated, asshown in Fig. 4B. These results dem- 
onstrate that isoprenylation is a strict prerequisite for mem- 
brane binding. 
4. Discussion 
Proteins belonging to the ras superfamily are believed to 
operate in a cyclic manner which involves hydrolysis of bound 
nucleotide and cytosolic and membrane bound forms of the 
proteins [29]. The association and dissociation of rab proteins 
with their target membranes appear to be results of multi-step 
processes [29,30]. Posttranslational modification of rab pro- 
teins by the rab geranylgeranyl-transferase at the two C-termi- 
nal cysteines initiate the rab protein life cycle [13,31]. Rab 
apoprotein is bound by REP protein, the component A of rab 
GGTase and then presented to the catalytic ~ and fl subunits 
of this enzyme [15]. In addition parts of the rab proteins other 
than the C-terminal sequences are required for the rab's iso- 
prenylation [32]. Recently Beranger et al. reported that loop 3 
and the hypervariable region of rab6 are structural require- 
ments for isoprenylation [17]. In addition, certain point muta- 
tions in the effector domain of rablB inhibit lipidation [32]. 
There is currently no consensus about the nucleotide require- 
ment for lipidation. Our results clearly prove that the confor- 
mation of rab6 induced by bound GDP is required for isopren- 
ylation. While the wildtype and a GDP-bound form of rab6 was 
modified in insect cells, rab6 Q72R protein did not display 
geranylgeranylation. Since the rab-GGTase acts on newly syn- 
thesized rab proteins it has to be concluded that cytosolic and 
thus GDP-bound rab protein is the preferential substrate of this 
enzyme. In vitro isoprenylation assays using the non hydrolysa- 
ble GTP-analogues GTP)'S or GppNHp led to ambiguous re- 
sults [17,18]. While Sanford et al. reported reduction of prenyl- 
ation of rab 5 preloaded with GTPyS, Beranger et al. observed 
normal processing of GTPyS bound rab6 [17,18]. To study the 
posttranslational modification of rab6 in vivo we used insect 
Sf9 cells. Yang and colleagues have shown previously that the 
rab6 wt protein becomes modified with geranylgeranyl residues 
after expression i  Sf9 cells, thus demonstrating that the insect 
cell system is a suitable tool to study isoprenylation [28]. 
Our results clearly show that rab6 wt and rab6 T27N un- 
dergo isoprenylation i insect cells. For the rab6 Q72R protein 
we were unable to detect any efficient lipid modification using 
both Triton X-114 separation and metabolic labeling with 
[3H]mevalonolactone. In the living cell rab proteins huttle be- 
tween the cytosolic GDP-bound form, and the membrane asso- 
ciated GTP-bound form. Two explanations are possible for the 
lack of rab6 Q72R prenylation. 
(1) This protein is not bound to the REP-protein. Alexan- 
drow et al. reported that REP-1 is associated with the GDP- 
bound form of the rab proteins [33]. After accompanying the 
rab-GDP complex to the target membrane the REP-protein is 
released and the GDP is exchanged to GTP. This behavior 
indicates that the REP protein similar to the GDI protein forms 
complexes predominantly with the GDP-bound form of rab 
proteins. 
(2) The catalytic a and fl subunits have a strong preference 
for rab proteins in the GDP conformation. In contrast o the 
GGTase I, which modifies rho proteins and even accepts hort 
peptides as substrates, the rab GGTase needs to interact not 
only with the C-terminus of rab proteins but also with remote 
parts of the polypeptide [17,32]. This fact emphasius that the 
three-dimensional structure seems to be an important prerequi- 
site for the rab6/rabGGTase interaction. The effector loop is 
a domain in ras-like proteins howing a major conformational 
change upon GTP/GDP switch. For the rablB protein Wilson 
and Maltese have shown that two point mutations in the effec- 
tor loop, I41N and D44N, reduce prenylation of the protein 
after translation in a reticulocyte lysate [32]. The same rab6 
region is affected by the amino acid change in rab6 Q72R. An 
alternative xplanation for the lack of rab6 Q72R isoprenyla- 
tion could be that not the change of the overall conformation 
but the point substitution of Gln 72 to Arg in loop 4 abolishes 
isoprenylation. However, this explanation seems unlikely since 
it was recently reported that loop 4 is not necessary for the 
modification of rab6 [17]. The fact that rab6 bound to GTPyS 
is prenylated in vitro by the purified rabGGTase as shown by 
Beranger et al. remains in contrast o our findings that rab6 
Q72R was not modified in insect cells. In support of our find- 
ings, the regulatory factors interacting with rab proteins are 
known to be conserved in all eukaryotic ells, from man to 
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yeast, thus making a different specificity of the rab GGTase in 
the insect cell unlikely. On the other hand, it is not known 
whether ab GGTase isolates have different requirements for 
the enzyme than in its physiological cellular enviroment. Both 
in the living cell as well as in reticulocyte lysate a whole array 
of different rab proteins compete as substrates for the GGTase. 
In such a competitive environment, rab proteins howing a less 
fa,lorable conformation may be not modified. 
Further experiments are needed to prove whether the nucle- 
ol de-dependent geranylgeranylation s a general behavior of 
ra 9 proteins or a specific characteristic of rab6. 
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